Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 16, 2024

SELL
$94.25 - $115.99 $565 - $695
-6 Closed
0 $0
Q3 2021

Aug 16, 2024

BUY
$80.98 - $109.47 $485 - $656
6 New
6 $617,000
Q2 2020

Aug 16, 2024

BUY
$57.09 - $79.27 $342 - $475
6 New
6 $468,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.02B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.